Ulab receives a Miquel Ruttlant research grant
Our project, “targeted nanoimmunotherapy against CXCR4+ leukaemic stem cells” has been awarded in the first edition of Miquel Ruttlant research grants, granted by Fundació Investigació Salut i Progress (FISP). This project focuses on the development of a new personalized therapeutic strategy based on nanoimmunotherapy for the treatment of acute myeloid leukemia (AML). The innovative approach […]